03:09 AM EST, 01/30/2025 (MT Newswires) -- Timothy Rolph, Chief Scientific Officer, on January 27, 2025, sold 31,250 shares in Akero Therapeutics ( AKRO ) for $1,742,958. Following the Form 4 filing with the SEC, Rolph has control over a total of 170,237 shares of the company, with 170,237 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1744659/000095017025010707/xslF345X05/ownership.xml